Editas Medicine (EDIT)
(Delayed Data from NSDQ)
$7.80 USD
+0.88 (12.72%)
Updated Sep 29, 2023 04:00 PM ET
After-Market: $7.74 -0.06 (-0.77%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/01/2023
Time: -- |
9/2023 | $-0.64 | 0.00% |
Earnings Summary
For their last quarter, Editas Medicine (EDIT) reported earnings of -$0.56 per share, beating the Zacks Consensus Estimate of $-0.76 per share. This reflects a positive earnings surprise of 26.32%. Look out for EDIT's next earnings release expected on November 01, 2023. For the next earning release, we expect the company to report earnings of -$0.64 per share, reflecting a year-over-year increase of 20.99%.
Earnings History
Price & Consensus
Zacks News for EDIT
Ligand (LGND) Down 8.8% Since Last Earnings Report: Can It Rebound?
EDIT: What are Zacks experts saying now?
Zacks Private Portfolio Services